Manchester Royal Eye Hospital (A.O., A.W., A.B., F.C.), Manchester University NHS Foundation Trust, Manchester, United Kingdom; and Division of Pharmacy & Optometry (V.R., A.J.M., H.R.), School of Health Sciences, Faculty of Biology, Medicine and Health, the University of Manchester, Manchester, United Kingdom.
Eye Contact Lens. 2020 Jul;46(4):254-261. doi: 10.1097/ICL.0000000000000697.
To assess publications examining the occurrence, composition, and clinical significance of a microbiome at the ocular surface.
MEDLINE, EMBASE, and Google Scholar were searched. Reference lists of included articles were also searched for relevant citations. All publications up to June 1, 2019, were analyzed.
Eleven articles and 1 abstract were included, analyzing 661 patients. Articles generally report bacteria to the genus level. The presence of DNA associated with diverse bacterial species was reported including pathogenic species, such as Pseudomonas and Neisseria. Bacterial DNA that makes up the microbiome, such as Acinetobacter, Actinomyces, Aquabacterium, Bradyrhizobium, Corynebacterium, Sphingomonas, Staphylococcus, and Streptococcus, in other parts of the body was found. The putative ocular microbiome is consistent between right and left eyes and is affected by contact lens use (higher Pseudomonas levels) and blepharitis (higher Staphylococcus levels).
There is a significant likelihood that there is at least a transitory ocular surface microbiome, with Acinetobacter, Corynebacterium, Propionibacterium, Staphylococcus, and Streptococcus detected in at least 7 of 11 studies. However, further investigation attempting to control for environmental and methodological contaminants (Aquabacterium and Bradyrhizobium are commonly identified as contaminants in DNA extraction kits) is required. Bacteria, such as Propionibacterium, Staphylococcus, and Streptococcus, capable of causing sight-threatening infections may reside on a healthy ocular surface. With greater understanding, we can establish whether elements of the ocular surface microbiome are harmful or protective (despite their small quantities); furthermore, new therapeutic agents can be identified to treat and prevent ocular surface infection and inflammation.
评估研究眼表微生物组发生、组成和临床意义的出版物。
检索 MEDLINE、EMBASE 和 Google Scholar,并对纳入文章的参考文献列表进行搜索以获取相关引文。分析截至 2019 年 6 月 1 日的所有出版物。
纳入 11 篇文章和 1 篇摘要,共分析了 661 例患者。文章通常报告细菌到属水平。报道了与多种细菌(包括假单胞菌和奈瑟菌等病原菌)相关的 DNA 存在。在身体其他部位,构成微生物组的细菌 DNA,如不动杆菌、放线菌、Aquabacterium、Bradyrhizobium、棒状杆菌、鞘氨醇单胞菌、葡萄球菌和链球菌,也被发现。右眼和左眼之间存在假设的眼表微生物组,并且受隐形眼镜使用(假单胞菌水平升高)和睑缘炎(葡萄球菌水平升高)的影响。
很可能存在至少是短暂的眼表微生物组,至少有 11 项研究中的 7 项检测到不动杆菌、棒状杆菌、丙酸杆菌、葡萄球菌和链球菌。然而,需要进一步的研究试图控制环境和方法学污染物(Aquabacterium 和 Bradyrhizobium 通常被鉴定为 DNA 提取试剂盒中的污染物)。能够引起威胁视力的感染的细菌,如丙酸杆菌、葡萄球菌和链球菌,可能存在于健康的眼表面。随着我们对眼表微生物组的了解,我们可以确定其是否对眼表有害或具有保护作用(尽管其数量很少);此外,还可以识别新的治疗剂来治疗和预防眼表感染和炎症。